For: | Liu CX, Gao Y, Xu XF, Jin X, Zhang Y, Xu Q, Ding HX, Li BJ, Du FK, Li LC, Zhong MW, Zhu JK, Zhang GY. Bile acids inhibit ferroptosis sensitivity through activating farnesoid X receptor in gastric cancer cells. World J Gastroenterol 2024; 30(5): 485-498 [PMID: 38414591 DOI: 10.3748/wjg.v30.i5.485] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v30/i5/485.htm |
Number | Citing Articles |
1 |
Na Liu, Jianzeng Zhang, Jiaojiao Wu, Fan Feng, Yantao Chai, Yongwu Li, Bo Liu. Targeting hepatocellular carcinoma growth and metabolism: A synergistic approach with para-toluenesulfonamide and radiofrequency ablation. iLIVER 2024; 3(3): 100111 doi: 10.1016/j.iliver.2024.100111
|
2 |
Fabrizio Termite, Sebastiano Archilei, Francesca D’Ambrosio, Lucrezia Petrucci, Nicholas Viceconti, Roberta Iaccarino, Antonio Liguori, Antonio Gasbarrini, Luca Miele. Gut Microbiota at the Crossroad of Hepatic Oxidative Stress and MASLD. Antioxidants 2025; 14(1): 56 doi: 10.3390/antiox14010056
|
3 |
Xiangxiang Wei, Yunquan He, Yueyang Yu, Sichong Tang, Ruiwen Liu, Jieyu Guo, Qingjun Jiang, Xiuling Zhi, Xinhong Wang, Dan Meng. The Multifaceted Roles of BACH1 in Disease: Implications for Biological Functions and Therapeutic Applications. Advanced Science 2025; doi: 10.1002/advs.202412850
|
4 |
Youchao Qi, Yonggui Ma, Guozhen Duan. Pharmacological Mechanisms of Bile Acids Targeting the Farnesoid X Receptor. International Journal of Molecular Sciences 2024; 25(24): 13656 doi: 10.3390/ijms252413656
|
5 |
Weiwei Cui, Meng Hao, Xin Yang, Chengqian Yin, Bo Chu. Gut microbial metabolism in ferroptosis and colorectal cancer. Trends in Cell Biology 2024; doi: 10.1016/j.tcb.2024.08.006
|
6 |
Tianyi Zhang, Chongjie Yao2, Xu Zhou, Shimin Liu, Li Qi, Shiguo Zhu, Chen Zhao, Dan Hu, Weidong Shen. Glutathione‑degrading enzymes in the complex landscape of tumors (Review). International Journal of Oncology 2024; 65(1) doi: 10.3892/ijo.2024.5660
|